The basal-like subtype is a triple-negative aggressive BC with a poor clinical outcome, consisting of a great proportion of breast cancer stem cells and characterized by the most common BCSC biomarkers, CD44+/CD24−/low and ALDH1+ [5]. This evidence concerns the gene CD24 and breast carcinoma.